Aadi Bioscience Inc
NASDAQ:AADI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aadi Bioscience Inc
NASDAQ:AADI
|
US |
|
Fractale Corp
TSE:3750
|
JP |
|
C
|
CMC JSC
VN:CVT
|
VN |
|
Pacific Current Group Ltd
ASX:PAC
|
AU |
|
E
|
Ekipa Holding SA
WSE:EEE
|
PL |
|
Nan Ya Plastics Corp
TWSE:1303
|
TW |
|
Sinch AB (publ)
STO:SINCH
|
SE |
|
A
|
Afrocentric Investment Corporation Ltd
JSE:ACT
|
ZA |
|
A
|
Ahnlab Inc
KOSDAQ:053800
|
KR |
|
Alset Capital Inc
XTSX:GPUS
|
CA |
|
Dal'nevostochnaya Energeticheskaya Kompaniya PAO
MOEX:DVEC
|
RU |
|
PTC Therapeutics Inc
NASDAQ:PTCT
|
US |
|
BRT Apartments Corp
NYSE:BRT
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AADI's stock price target?
Not Available
AADI doesn't have any price targets made by Wall Street professionals.
What is Aadi Bioscience Inc's Revenue forecast?
Projected CAGR
30%
The
compound annual growth rate
of
Aadi Bioscience Inc's revenue for the next 4 years is
30%.